Cargando…
Commentary: Is Torasemide a Potential Agent in the Treatment of Autism?
Autores principales: | Machado, Sergio, Lucas Lima, João, Imperatori, Claudio, Souza de Sá Filho, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVES
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985063/ https://www.ncbi.nlm.nih.gov/pubmed/36879994 http://dx.doi.org/10.5152/alphapsychiatry.2023.27122022 |
Ejemplares similares
-
Neuropsychiatric Consequences of COVID-19: What Do We Know So Far?
por: Machado, Sergio, et al.
Publicado: (2022) -
Subjective Cognitive Decline and Quality of Life During Aging: A Thin Line Between Healthy and Pathological?
por: Machado, Sergio, et al.
Publicado: (2023) -
Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study
por: Doğan, Murat, et al.
Publicado: (2023) -
Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats
por: Roche‐Catholy, Marine, et al.
Publicado: (2022) -
Health-Related Fitness as a Predictor of Anxiety Levels Among School Adolescents: An observational cross-sectional study
por: Legey, Sandro, et al.
Publicado: (2022)